Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1- A Canadian Cost-Utility Analysis
May 1, 2018, 00:00
10.1016/j.jval.2018.04.044
https://www.valueinhealthjournal.com/article/S1098-3015(18)30344-9/fulltext
Title :
Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1- A Canadian Cost-Utility Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30344-9&doi=10.1016/j.jval.2018.04.044
First page :
Section Title :
Open access? :
No
Section Order :
1394